Cyber Monday saleUp to 70% OFF
BBB

BIO VIEW

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

BIOV chart


Full chart

Key stats


Market capitalization
‪34.44 M‬ ILS
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
44.2
Basic EPS (TTM)
0.0 ILS
Net income (FY)
‪383.00 K‬ ILS
Revenue (FY)
‪34.77 M‬ ILS
Shares float
—
Beta (1Y)
0.69

Employees


Employees (FY)
33
Change (1Y)
−1 −2.94%
Revenue / Employee (1Y)
‪290.16 K‬ ILS
Net income / Employee (1Y)
‪3.20 K‬ ILS

About BIO VIEW


Sector
Health Technology
Industry
Medical Specialties
Headquarters
Rehovot
Website
bioview.com
Founded
1998
ISIN
IL0010960495
FIGI
BBG000Q6J3W5
BioView Ltd. engages in the research, development, marketing, and sales of imaging systems computerized to identify abnormal cells. It operates throug the following geographical segments: North America, Asia, and Countries in EMEA. The company was founded by Yuval Harari on August 18, 1998 and is headquartered in Rehovot, Israel.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BIOV is 26.9 ILA — it has increased by 0.38% in the past 24 hours. Watch BIO VIEW stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange BIO VIEW stocks are traded under the ticker BIOV.
BIOV stock has risen by 1.91% compared to the previous week, the month change is a −13.59% fall, over the last year BIO VIEW has showed a −92.18% decrease.
BIOV reached its all-time high on Apr 12, 2017 with the price of 515.0 ILA, and its all-time low was 21.9 ILA and was reached on Jun 16, 2024. View more price dynamics on BIOV chart.
See other stocks reaching their highest and lowest prices.
BIOV stock is 2.63% volatile and has beta coefficient of 0.69. Track BIO VIEW stock price on the chart and check out the list of the most volatile stocks — is BIO VIEW there?
Today BIO VIEW has the market capitalization of ‪34.44 M‬, it has decreased by −16.01% over the last week.
Yes, you can track BIO VIEW financials in yearly and quarterly reports right on TradingView.
BIOV net income for the last half-year is ‪1.96 M‬ ILS, while the previous report showed ‪−1.07 M‬ ILS of net income which accounts for 282.59% change. Track more BIO VIEW financial stats to get the full picture.
No, BIOV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 3, 2024, the company has 33.00 employees. See our rating of the largest employees — is BIO VIEW on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIO VIEW EBITDA is ‪1.95 M‬ ILS, and current EBITDA margin is 5.62%. See more stats in BIO VIEW financial statements.
Like other stocks, BIOV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO VIEW stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIO VIEW technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIO VIEW stock shows the sell signal. See more of BIO VIEW technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.